Lipitor, Zocor and Pravachol Show Equal Rhabdomyolysis Risk – JAMA Article
This article was originally published in The Pink Sheet Daily
Executive Summary
The top three statins have a roughly equivalent risk of rhabdomyolysis, a study of health plan prescription data published in the Journal of the American Medical Association concludes
You may also be interested in...
FDA Drug Safety Initiative Is "Inadequate," JAMA Editorial Says
IoM study of drug safety system is "appropriate," but the "initial steps" proposed by FDA are not enough "to restore the trust and confidence necessary" for agency's public health mission. JAMA editors propose independent drug safety agency, with mandatory Phase IV studies.
Crestor, Serevent Are Among Problem Drugs Cited By FDA Safety Reviewer
FDA Office of Drug Safety personnel will be publishing a paper on statins and rhabdomyolysis in an upcoming issue of the Journal of the American Medical Association, Associate Director for Science David Graham told the Senate Finance Committee during a Nov. 18 hearing on Merck's withdrawal of Vioxx
Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability